Australian CPI rise in pharmaceuticals 'due to PBS safety net'

28 April 2011

The apparent surge in pharmaceutical prices included in yesterday’s Australian Bureau of Statistics Consumer Price Index for the March quarter is easily explained by the mechanics of the Pharmaceutical Benefits Scheme safety net, said trade group Medicines Australia chief executive Brendan Shaw.

The ABS figures showed that pharmaceutical prices had increased 12.5% for the March 2011 quarter.

“Today’s CPI pharmaceutical price should be considered in the context of the December 2010 CPI, when pharmaceutical prices fell 6.2%,” Dr Shaw said, adding: “The fall of the pharmaceutical price index throughout the year to December 2010 quarter was largely due to patients reaching the PBS safety net and paying either a reduced co-payment in the case of general patients, or no co-payment in the case of concession card holders. As each calendar year progresses, more people reach the PBS safety net.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical